R. Kekuda et al., Polarized distribution of interleukin-1 receptors and their role in regulation of serotonin transporter in placenta, J PHARM EXP, 292(3), 2000, pp. 1032-1041
Citations number
41
Categorie Soggetti
Pharmacology & Toxicology
Journal title
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
We investigated the expression of interleukin-1 (IL-1) receptors and their
involvement in the regulation of the serotonin transporter gene expression
in human placenta. IL-1 beta is an activator of the serotonin transporter g
ene expression in JAR human placental choriocarcinoma cells as demonstrated
by an increase in the steady-state levels of the transporter mRNA and in s
erotonin transport activity. This activation is blocked by IL-1 receptor an
tagonist. Genistein also blocks the effect of IL-1 beta, indicating involve
ment of tyrosine phosphorylation in the process. Treatment of JAR cells wit
h IL-1 beta activates mitogen-activated protein kinases and nuclear factor-
kappa B. The nuclear factor-kappa B that is responsive to IL-1 beta in thes
e cells is the p65 homodimer. Northern blot analysis and reverse transcript
ion-polymerase chain reaction revealed that JAR cells and human placenta ex
press type I and type II IL-1 receptors. The binding sites for I-125-IL-1 b
eta are localized predominantly in the maternal-facing brush border membran
e of the syncytiotrophoblast. These results show that IL-1 in the maternal
circulation is likely to play a critical role in the regulation of the sero
tonin transporter gene expression in the placenta.